For Access and Reimbursement Support

Physician resources

Select all

CAR-T=chimeric antigen receptor T-cell; REMS=Risk Evaluation and Mitigation Strategy.

Nurse/APP resources

As nurses and advanced practice providers (APPs), your role is vital at every step. Use these resources to help strengthen your practice and deliver care with more confidence and certainty.

Select all

DownloadViewLink

Advanced Practice Providers and Oncology Nurse Treatment PERSPECTIVES™ educational hub

CARVYKTI APP Oncology Nurses thumbnail

Looking for the latest educational CARVYKTI® videos and resources? Click here to visit our on-demand educational hub.

CARVYKTI APP Oncology Nurses thumbnail

VISIT THE EDUCATIONAL HUB

Ongoing support starts here

Your role on the patient care team is unique. That’s why we’re creating a unique set of tools and resources specifically for nurses and APPs. Bookmark this page and check back soon.

In the meantime, support is just a click away.

Get in Touch

Patient resources

Select all

Choose your language:

DownloadViewLink

Care partner resources

Select all

Choose your language:

DownloadViewLink

Additional resources for patients and care partners

The organizations listed here are independent from and not sponsored by Johnson & Johnson, or Legend Biotech, and this list is subject to change. This information is provided as a resource for healthcare professionals, patients, and care partners, and is not an endorsement or guarantee of assistance.

Clicking on any of the links below will take you to an online service, the content for which Johnson & Johnson is not responsible and to which this Privacy Statement does not apply. We encourage you to read the Privacy Statement of every online service you visit.

The American Cancer Society
https://www.cancer.org/cancer/multiple-myeloma.html

The American Society of Clinical Oncology
https://www.asco.org

CancerCare
https://www.cancercare.org/

Cancer Support Community
https://cancersupportcommunity.org

HealthTree Foundation
https://healthtree.org/

The International Myeloma Foundation
https://www.myeloma.org

Leukemia and Lymphoma Society
https://www.lls.org/support/financial-support

Multiple Myeloma Research Foundation
https://themmrf.org

Myeloma Crowd
https://www.myelomacrowd.org/healthtree/

MyCARVYKTI® Patient Support Program

The MyCARVYKTI® Patient Support Program, sponsored by Johnson & Johnson and Legend Biotech, is designed to help eligible patients prescribed CARVYKTI® and their care partners with support during treatment at an Activated Treatment Center.

MyCARVYKTI® may offer support with:

Transportation

MyCARVYKTI® may provide assistance with ground or air transportation costs to and from the CARVYKTI® Activated Treatment Center for each approved treatment trip. Transportation support may include mileage reimbursement, bus, rail, or air travel.

Lodging

MyCARVYKTI® may cover the cost of lodging accommodations near the Activated Treatment Center. All arrangements will be made by the MyCARVYKTI® travel provider. Travel support is available 24/7, 365 days a year, to support eligible patients and their care partner(s).

Meals and Out-of-Pocket Travel Expenses

MyCARVYKTI® may reimburse a daily per diem for costs related to meals and other out-of-pocket travel expenses for approved trips related to CARVYKTI® treatment

Who is eligible for MyCARVYKTI®?

  • To participate in MyCARVYKTI®, patients must have been prescribed CARVYKTI® and meet distance and income eligibility
  • A care partner may be required to accompany the patient during infusion and monitoring in order to receive support
  • Participants must reside in the United States or its territories
  • Support benefits that are provided by the patient's health insurance plan and Activated Treatment Center must be used prior to utilizing benefits from the program, as the program does not provide duplicative support
Woman smiling while wearing a headset

Dedicated patient support

Our dedicated Patient Support Specialists will assist patients with the application process. In fact, enrollment can easily be completed over the phone.

  • We encourage patients to reach out to the program as soon as they have been prescribed CARVYKTI® treatment so we can determine eligibility for our support offerings
  • We offer real-time translation support when needed to ensure that every eligible patient receives assistance throughout their treatment journey

Get your patients started with MyCARVYKTI®

Explore the following information to learn more about the MyCARVYKTI® Patient Support Program. Have questions? Use the phone number listed below to connect with a specialist.

Contact MyCARVYKTI®

To get your eligible patients started, contact a MyCARVYKTI® patient support specialist at:

800-559-7875

Monday to Friday, 8 AM – 8 PM Eastern Time

MyCARVYKTI® Patient Brochure

Provide your eligible patients and their care partner(s) with an overview of the MyCARVYKTI® Patient Support Program

DownloadView

Reimbursement resources

Select all

Download View Link

This website is presented for informational purposes only and is not intended to provide reimbursement or legal advice, nor does it promise or guarantee coverage, levels of reimbursement, payment, or charge.

Similarly, all CPT and HCPCS codes are supplied for informational purposes only and represent no statement, promise, or guarantee by Johnson & Johnson that these codes will be appropriate or that reimbursement will be made.

This website is not intended to increase or maximize reimbursement by any payer. Laws, regulations, and policies concerning reimbursement are complex and are updated frequently. While we have made an effort to be current as of the issue date of this website, the information may not be current or comprehensive when you view it. We strongly recommend you consult each payer organization for its reimbursement policies.

This communication is solely the responsibility of Johnson & Johnson.

CARVYKTI® coverage lookup tool

Search a database of state- and payer-specific forms and coverage documents for CARVYKTI®

Not all plans that cover CARVYKTI® are listed. Coverage relevant to your patients may vary. Status is representative of the coverage for the majority of members covered under each plan.

This information does not give advice or promise coverage or payment. Legal requirements and plan information can be updated frequently. Contact the plan for more information about current coverage, restrictions, or requirements that may apply. Nothing herein may be construed as an endorsement, approval, recommendation, representation, or warranty of any kind by any plan or insurer referenced herein. This communication is solely the responsibility of Johnson & Johnson.

Order CARVYKTI® with confidence, the #1 prescribed CAR-T cell therapy for RRMM1*

Johnson & Johnson and Legend Biotech are committed to achieving reliable and timely delivery of CARVYKTI® to patients.

99%

success in CAR-T cell manufacturing1†

CARVYKTI® deliveries PLUS cilta-cel deliveries released under Expanded Access Program

DIVIDED BY

Patients who underwent leukapheresis for CARVYKTI® MINUS orders cancelled for non-manufacturing-related reasons

Our widespread network of CARVYKTI® Activated Treatment Centers can book up to 3 months in advance with

no monthly booking limit

Median turnaround time improved to

~4 weeks

from apheresis to product release1‡

Over

10,000

patients treated worldwide

Order on your schedule so we can deliver on theirs

A medical worker typing on a computer, followed by a man and child playing video games

Online and live support for CARVYKTI® Activated Treatment Centers

CQUENCE, logo

Connecting people, processes, and technology for end-to-end order management

CQUENCE® is designed to track the end-to-end order management journey from patient enrollment to product infusion. If you are at an Activated Treatment Center and ready to prescribe and order CARVYKTI® for one of your patients, access the CQUENCE® portal  with your login credentials.

If you do not have your login information, contact your dedicated CTEL or call 1-833-CQORDER (1-833-276-7337).

Dedicated personnel to support order management and fulfillment:

  • Cell Therapy Experience Lead (CTEL), a process expert responsible for the end-to-end center utilization experience, including upfront and ongoing education on CQUENCE®
  • CQUENCE® Order Specialist to provide support with order tracking and operations coordination post order placement
CARVYKTI® Order Fulfillment, PDF thumbnail
CARVYKTI® Order Fulfillment Brochure

Explore how CARVYKTI® is supporting order fulfillment every step of the way.

DownloadView

CAR-T=chimeric antigen receptor-T cell; RRMM=relapsed or refractory multiple myeloma.

*Through October 2025.

January 2025–December 2025.

Median turnaround time = the number of days from apheresis pickup to quality release for commercial product. For 3290 CARVYKTI orders released between January 2025 and December 2025, median turnaround time was 29 days.

§Through January 2026.

Get resources for your CARVYKTI® patients